Search Results

Medical experts at Stanford and their colleagues at several other universities have raised ethical questions about the way a treatment for spinal muscular atrophy is being used.

The implications of emerging biotechnologies and what they mean for human reproduction and making babies raises legal, ethical and social issues, according to law professor Hank Greely.